ALBANESE, Nadia Ninfa
ALBANESE, Nadia Ninfa
Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche
A combined determination of circulating gelatinases and inflammatory markers in breast cancer patients during therapeutic treatment
2008-01-01 MARABETI MR; DI CARA G; CANCEMI P; ALBANESE NN; COSTANTINI F; TAORMINA P; MARRAZZO A; PUCCI-MINAFRA I
A multiomics analysis of S100 protein family in breast cancer
2018-06-26 Cancemi, Patrizia; Buttacavoli, Miriam; Cara, Gianluca Di; Albanese, Nadia Ninfa; Bivona, Serena; Pucci-Minafra, Ida; Feo, Salvatore
A PROTEOMIC CLUSTER FOR OSTEOTROPIC BREAST CANCER CELLS
2014-01-01 Di Cara, G; Musso, R; Albanese, NN; Cancemi, P; Peri, G; Valentino, B; D’Arienzo, M; Martini, D; Raspanti, M; Minafra, S; Pucci, I
AN IN VITRO MODEL TO STUDY BONE METASTASIS
2013-01-01 I. Pucci Minafra, G. Di Cara, R. Musso, N.N. Albanese, P. Cancemi, G. Peri, B. Valentino, M. D’Arienzo, M. Ferruzza, D. Martini, M. Raspanti
Analisi comparativa tra linee cellulari di carcinoma tiroideo papillare ed anaplastico
2013-01-01 Musso, R; Di Cara, G; Albanese, NN; Marabeti, MR; Cancemi, P; Martini, D; Orsini, E; Giordano, C ; Pucci, I
Analisi di cluster proteomici per l'identificazione di sottopopolazioni di pazienti con carcinoma mammario
2013-01-01 Albanese, NN; Cancemi, P; Di Cara, G; Musso, R; Lupo, C; Roz E; Riili, I; Pucci, I
Analysis of Trastuzumab effects in breast cancer cells in vitro
2011-01-01 Di Cara, G; Albanese, NN; Musso, R; Costantini, F; Marabeti MR; Cancemi, P; Pucci, I
Anti-oncogenic role of decorin: identification of new markers.
2009-01-01 DI CARA G; MINAFRA L; CANCEMI P; ALBANESE NN; MARABETI MR; FEO S; PUCCI, I
Assessing the Impact of Copy Number Variants on miRNA Genes in Autism by Monte Carlo Simulation
2014-01-01 Marrale, M; Albanese, N.N; Francesco Calı`, F; Romano, V
AUTOANTIBODIES IDENTIFICATION IN BREAST CANCER SERA BY PROTEOMIC APPROACH
2011-01-01 Cancemi, P; Albanese, NN; Di Cara, G; Marabeti, MR; Musso, R; Roz, E; Lupo, C; Pucci, I
BEHAVIOVRAL CHANGES OF BREAST CANCER CELLS IN VITRO
2011-01-01 Pucci-Minafra, I; Cancemi, P; Albanese, NN; Di Cara, G; Marabeti, MR; Musso, R; Minafra, S
Breast cancer cells exhibit selective modulation induced by different collagen substrates.
2008-01-01 Pucci, I.; Albanese, N.; DI CARA, G.; Minafra, L.; Marabeti, M.; Cancemi, P.
Breast cancer proteomics: from research to clinical applications.
2008-01-01 PUCCI-MINAFRA I; CANCEMI P; ALBANESE NN; DI CARA G; MARABETI MR; MARRAZZO A; MINAFRA S
Caratterizzazione proteomica di una linea beta cellulare resistente all'effetto citochinico
2012-01-01 Tomasello, L; Coppola, A; Pizzolanti, G; Albanese, NN; Pitrone, M; Criscimanna, A; Giordano Galluzzo, C
CHARACTERIZATION OF PAR6 INTERACTORS IN 8701-BC BREAST CANCER CELL LINE
2014-01-01 Boscarino, A;Di Cara, G; Albanese, NN; Pucci-Minafra, I; Cancemi, P.
CIRCULATING AND TISSUE FORMS OF MMP2 AND MMP9 IN BREAST CANCER PROGRESSION
2010-01-01 Marabeti, MR; Cancemi, P; Pivetti, A; Di Cara, G; Albanese, NN; Costantini, F; Musso, R; Pucci, I
Circulating levels of Matrix Metalloproteinases (MMP-2 and MMP-9), CRP and IL-6 during therapeutic treatment of patients with breast cancer
2008-01-01 MARABETI MR; DI CARA G; CANCEMI P; ALBANESE NN; TAORMINA P; MARRAZZO A; PUCCI-MINAFRA I
Clinicopathological correlations of MMP-2 and MMP-9 in breast cancer
2009-01-01 Marabeti, MR; Cancemi, P; Albanese, NN; Di Cara, G; Costantini, F; Musso, R; Roz, E; Lupo, C; Marrazzo, A; Pucci, I
Comparative detection of matrix metalloproteinase-2 and -9, interleukin-6 and c-reactive protein in breast cancer serum of patients during neoadjuvant chemotherapy
2007-01-01 Marabeti, M.; Cancemi, P.; DI CARA, G.; Albanese, N.; Taormina, P.; Marrazzo, A.; Pucci, I.
COMPARATIVE PROFILING BY PROTEOMICS AND ZYMOGRAPHIC ACTIVITIES OF TUMORAL AND NON TUMORAL CELL LINES
2015-01-01 Musso, R; Di Cara, G; Albanese, NN; Cancemi, P; Martini, D; Giordano, C; Pucci-Minafra, I